Movement Alert｜Praxis Precision Medicines Rises 5.02% in Regular Trading, Trading at $283.05

Market Focus06-19

On June 19, Praxis Precision Medicines rose 5.02% in regular trading, trading at $283.05 USD/share, with Turnover of $57.06 million.

Within the Biotechnology sector where Praxis Precision Medicines belongs, individual stocks showed mixed performance. Among individual stocks, CervoMed up 7.74%, Moderna, Inc. up 4.05%, Amgen down 1.83%, AbbVie down 2.06%, Gilead Sciences down 1.98%.

Praxis Precision Medicines is a clinical-stage biopharmaceutical company that develops therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance, with key pipeline assets including ulixacaltamide for essential tremor and Parkinson's disease, PRAX-562 for developmental and epileptic encephalopathies, and PRAX-628 for focal epilepsy.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1106982805?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-19 02:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1106982805","market":"us","top_or_hot":-1,"title":"Movement Alert｜Praxis Precision Medicines Rises 5.02% in Regular Trading, Trading at $283.05","media":"Market Focus","content":"<p><p>On June 19, Praxis Precision Medicines rose 5.02% in regular trading, trading at $283.05 USD/share, with Turnover of $57.06 million.</p><p>Within the Biotechnology sector where Praxis Precision Medicines belongs, individual stocks showed mixed performance. Among individual stocks, CervoMed up 7.74%, Moderna, Inc. up 4.05%, Amgen down 1.83%, AbbVie down 2.06%, Gilead Sciences down 1.98%.</p><p>Praxis Precision Medicines is a clinical-stage biopharmaceutical company that develops therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance, with key pipeline assets including ulixacaltamide for essential tremor and Parkinson's disease, PRAX-562 for developmental and epileptic encephalopathies, and PRAX-628 for focal epilepsy.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Praxis Precision Medicines Rises 5.02% in Regular Trading, Trading at $283.05</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Praxis Precision Medicines Rises 5.02% in Regular Trading, Trading at $283.05\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-19 02:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 19, Praxis Precision Medicines rose 5.02% in regular trading, trading at $283.05 USD/share, with Turnover of $57.06 million.</p><p>Within the Biotechnology sector where Praxis Precision Medicines belongs, individual stocks showed mixed performance. Among individual stocks, CervoMed up 7.74%, Moderna, Inc. up 4.05%, Amgen down 1.83%, AbbVie down 2.06%, Gilead Sciences down 1.98%.</p><p>Praxis Precision Medicines is a clinical-stage biopharmaceutical company that develops therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance, with key pipeline assets including ulixacaltamide for essential tremor and Parkinson's disease, PRAX-562 for developmental and epileptic encephalopathies, and PRAX-628 for focal epilepsy.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PRAX","symbol_name":"Praxis Precision Medicines, Inc.","start_time":0,"source_url":"","article_id":"1106982805","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1106982805","pubTimestamp":1781807546,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 19, Praxis Precision Medicines rose 5.02% in regular trading, trading at $283.05 USD/share, with Turnover of $57.06 million.Within the Biotechnology sector where Praxis Precision Medicines...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PRAX":"Praxis Precision Medicines, Inc."},"translate_title":"走势提示|Praxis Precision Medicines常规交易上涨5.02%，报283.05美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PRAX":1},"content_text":"On June 19, Praxis Precision Medicines rose 5.02% in regular trading, trading at $283.05 USD/share, with Turnover of $57.06 million.Within the Biotechnology sector where Praxis Precision Medicines belongs, individual stocks showed mixed performance. Among individual stocks, CervoMed up 7.74%, Moderna, Inc. up 4.05%, Amgen down 1.83%, AbbVie down 2.06%, Gilead Sciences down 1.98%.Praxis Precision Medicines is a clinical-stage biopharmaceutical company that develops therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance, with key pipeline assets including ulixacaltamide for essential tremor and Parkinson's disease, PRAX-562 for developmental and epileptic encephalopathies, and PRAX-628 for focal epilepsy.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1106982805","isCrawlerRequest":true}